![logo](/logos/326030.KS.webp)
SK Biopharmaceuticals Co., Ltd.
KRX:326030.KS
105,000 (KRW) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SK Biopharmaceuticals Co., Ltd. |
Symbool | 326030.KS |
Munteenheid | KRW |
Prijs | 104,100 |
Beurswaarde | 8,152,414,530,000 |
Dividendpercentage | 0% |
52-weken bereik | 72,600 - 119,500 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Dong Hoon Lee |
Website | https://www.skbp.com |
An error occurred while fetching data.
Over SK Biopharmaceuticals Co., Ltd.
SK Biopharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research, discovery, and development of drugs for the treatment of central nervous system disorders. The company is developing Cenobamate for the treatment of epilepsy; Solriamfetol for the treatment of excessive daytime sleepiness in narcolepsy or obstructive sleep apneal; Carisbamate that
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)